Accreditation

Applying standards to pharmaceutical management of ectopic pregnancy

Briefings on Accreditation and Quality, April 1, 2010

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on Accreditation and Quality.

Ectopic pregnancy will be used throughout this article to illustrate some of the 2010 standards, highlighting The Joint Commission’s addition of hazardous medications to several standards in 2009. The purpose of this article is illustrating the application of several standards to a health condition.

A detailed procedure for diagnosing and treating patients with unruptured ectopic pregnancy is not provided and is beyond the scope of this article. This health condition is a good choice for the purpose of this illustration because it is the leading cause of maternal death in the first trimester of pregnancy and The Joint Commission’s most recent Sentinel Event Alert specifically addresses maternal death (See Issue 44: Preventing Maternal Death released on January 26, 2010).

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on Accreditation and Quality.

Most Popular